|
PDPR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.1477999640781E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.5420000548948E-09 |
| Normal-vs-Stage2 |
1.80202999999768E-05 |
| Normal-vs-Stage3 |
6.73140432283503E-11 |
| Normal-vs-Stage4 |
9.69369029490963E-12 |
| Stage1-vs-Stage2 |
3.474200E-01 |
| Stage1-vs-Stage3 |
8.315900E-02 |
| Stage1-vs-Stage4 |
7.443500E-03 |
| Stage2-vs-Stage3 |
4.116000E-02 |
| Stage2-vs-Stage4 |
1.540350E-02 |
| Stage3-vs-Stage4 |
3.834400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.5546000042832E-09 |
| Normal-vs-AfricanAmerican |
6.07930000007251E-07 |
| Normal-vs-Asian |
1.91047178077497E-12 |
| Caucasian-vs-AfricanAmerican |
8.860800E-01 |
| Caucasian-vs-Asian |
1.738820E-03 |
| AfricanAmerican-vs-Asian |
7.479500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.41389999708252E-09 |
| Normal-vs-Female |
6.02589977916068E-10 |
| Male-vs-Female |
9.442200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.19129994547285E-09 |
| Normal-vs-Age(41-60Yrs) |
3.49440032465509E-10 |
| Normal-vs-Age(61-80Yrs) |
1.18900000956046E-09 |
| Normal-vs-Age(81-100Yrs) |
3.298600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.157400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.662000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.721000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.026000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.045400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.670600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.57470000000349E-05 |
| Classical-VS-Follicular |
6.106000E-01 |
| Classical-VS-Other |
4.946800E-01 |
| Classical-VS-Normal |
3.83950005122813E-09 |
| Tall-VS-Follicular |
4.169300E-04 |
| Tall-VS-Other |
2.807400E-01 |
| Tall-VS-Normal |
2.11797246407741E-12 |
| Follicular-VS-Other |
4.651600E-01 |
| Follicular-VS-Normal |
2.88579999896399E-08 |
| Other-VS-Normal |
3.064300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.15739995365516E-09 |
| Normal-vs-N1 |
5.49720047260394E-10 |
| N0-vs-N1 |
2.676800E-01 |
|
|
